CFDE Data Portal | Search LINC01907

	Label	Description
	LINC01907 Gene (Entity type)	ENSG00000226125 - long intergenic non-protein coding RNA 1907
	GSE216988 GSE216989 decitabine 0 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE56010 adenosine 4 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE186226 KD knockdown T24 1 v 0 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE153354 TCF19 knockout CAL-27 0 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE111247 temozolomide LN-308 14 v 6 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE68925 fasudil 1 v 0 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE181517 doxorubicin 0 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE115384 CELSR2 knockdown 6 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE179235 MEK NRAS inhibition 0 v 3 human up Gene Set (Entity type)	A Gene Set from LINCS

LINC01907

ENSG00000226125 - long intergenic non-protein coding RNA 1907

GSE216988 GSE216989 decitabine 0 v 1 human up

A Gene Set from LINCS

GSE56010 adenosine 4 v 1 human dn

A Gene Set from LINCS

GSE186226 KD knockdown T24 1 v 0 human dn

A Gene Set from LINCS

GSE153354 TCF19 knockout CAL-27 0 v 1 human dn

A Gene Set from LINCS

GSE111247 temozolomide LN-308 14 v 6 human up

A Gene Set from LINCS

GSE68925 fasudil 1 v 0 human up

A Gene Set from LINCS

GSE181517 doxorubicin 0 v 1 human up

A Gene Set from LINCS

GSE115384 CELSR2 knockdown 6 v 1 human up

A Gene Set from LINCS

GSE179235 MEK NRAS inhibition 0 v 3 human up

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.